These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11099266)

  • 1. Atypical antipsychotics.
    Kapur S; Remington G
    BMJ; 2000 Dec; 321(7273):1360-1. PubMed ID: 11099266
    [No Abstract]   [Full Text] [Related]  

  • 2. Benzodiazepines, benzodiazepine-like drugs, and typical antipsychotics impair manual dexterity in patients with schizophrenia.
    Sasayama D; Hori H; Teraishi T; Hattori K; Ota M; Matsuo J; Kinoshita Y; Okazaki M; Arima K; Amano N; Higuchi T; Kunugi H
    J Psychiatr Res; 2014 Feb; 49():37-42. PubMed ID: 24262979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia.
    Ritchie CW; Chiu E; Harrigan S; Hall K; Hassett A; Macfarlane S; Mastwyk M; O'Connor DW; Opie J; Ames D
    Int J Geriatr Psychiatry; 2003 May; 18(5):432-40. PubMed ID: 12766921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic safety and efficacy concerns.
    Meyer JM
    J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinematic analysis of handwriting movements in schizophrenic patients.
    Gallucci RM; Phillips JG; Bradshaw JL; Vaddadi KS; Pantelis C
    Biol Psychiatry; 1997 Apr; 41(7):830-3. PubMed ID: 9084903
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical antipsychotic agents: a critical review.
    Worrel JA; Marken PA; Beckman SE; Ruehter VL
    Am J Health Syst Pharm; 2000 Feb; 57(3):238-55. PubMed ID: 10674777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Typical and atypical antipsychotics: Is there a difference in their influence on neurocognition?].
    Faber G; van Gool AR; Smid HG; Wiersma D; van den Bosch RJ
    Tijdschr Psychiatr; 2011; 53(2):107-17. PubMed ID: 21319067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
    Soyka M; Winter C; Kagerer S; Brunnauer M; Laux G; Möller HJ
    J Psychiatr Res; 2005 Jan; 39(1):101-8. PubMed ID: 15504428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia.
    Ollendorf DA; Joyce AT; Rucker M
    MedGenMed; 2004 Jan; 6(1):5. PubMed ID: 15208518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics in the treatment of schizophrenia. Users' experiences of treatments must be considered.
    Prior C; Clements J; Rowett M
    BMJ; 2001 Apr; 322(7291):924-5; author reply 927-8. PubMed ID: 11302924
    [No Abstract]   [Full Text] [Related]  

  • 13. Schizophrenia, weight gain and atypical antipsychotics.
    Brown S
    Br J Psychiatry; 2006 Feb; 188():191-2. PubMed ID: 16449712
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences of satisfaction with medication between patients with schizophrenia treated with typical antipsychotics and atypical antipsychotics.
    Watanabe A; Shibata I; Kato T
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):268-73. PubMed ID: 15149292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotics in the treatment of schizophrenia. Users' views are important.
    Anderson I
    BMJ; 2001 Apr; 322(7291):926; author reply 927-8. PubMed ID: 11302919
    [No Abstract]   [Full Text] [Related]  

  • 16. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.
    Toren P; Ratner S; Laor N; Weizman A
    Drug Saf; 2004; 27(14):1135-56. PubMed ID: 15554747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring unwanted effects of antipsychotics.
    Drug Ther Bull; 2011 Oct; 49(10):117-20. PubMed ID: 21994439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reaction on 'typical and atypical antipsychotics: is there a difference in their influence on neurocognition?'].
    van Oeffelt T
    Tijdschr Psychiatr; 2011; 53(4):255-6; author reply 256-7. PubMed ID: 21506082
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential pharmacology of atypical antipsychotics: clinical implications.
    Masand PS
    Am J Health Syst Pharm; 2007 Jan; 64(2 Suppl 1):S3-8; quiz S24-5. PubMed ID: 17215475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.